The largest database of trusted experimental protocols

Siinfekl

Manufactured by BioLegend
Sourced in United States

SIINFEKL is a synthetic peptide that can be used in cell biology research. It serves as an immunogenic epitope derived from the ovalbumin protein. This peptide can be utilized in various experimental applications.

Automatically generated - may contain errors

4 protocols using siinfekl

1

SIINFEKL Exchange on K^b-NPs

Check if the same lab product or an alternative is used in the 5 most similar protocols
To exchange the native peptide with SIINFEKL (Peptron, Daejeon, Korea), 5 mg of Kb-attached NPs was incubated with 20 μM or 100 μM SIINFEKL for 18 h at 37°C, washed twice with PBS, and resuspended in 0.5 ml of PBS. The level of SIINFEKL bound to the Kb-attached NPs was analyzed with mAbs recognizing the SIINFEKL-Kb complex (25-D1.16; BioLegend).
+ Open protocol
+ Expand
2

Ova-Specific CD8+ T Cell Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Before the treatment day, Raw264.7-H2Kb cells were pretreated with recombinant murine GMCSF (400 U/mL = 20 ng/mL, Peprotech, US) overnight. GMCSF was also present in the treatment media. On the treatment day, cells (0.1 × 106 per well in 96-well plates) were incubated with 1000 μg/mL ovalbumin (Ovalbumin EndoFit, Invivogen, France) or 10 μg/mL OT1 long peptides (Agenus, US) or 10 μg/mL E7 peptides (Agenus, US) or 10 μg/mL SIINFEKL (GenScript, China) and the indicated adjuvants as well as inhibitors for 6 h in a 37°C incubator. Then media was removed. Cells were washed and stained with an anti-mouse H-2Kb bound to SIINFEKL antibody (Clone 25-D1.16, Cat 141604, BioLegend, US) as well as LIVE/DEAD Fixable Near-IR Dead Cell Stain reagent (ThermoFisher, US) for flow cytometry analysis.
+ Open protocol
+ Expand
3

Engineered TRAMP-C2 Cells Express OVA and mEGFP

Check if the same lab product or an alternative is used in the 5 most similar protocols
Soluble OVA gene, which was amplified from pCI-neo-sOVA (a gift from Maria Castro, Addgene plasmid 25 09818 (link)), and monomeric enhanced green fluorescent protein (mEGFP) gene, which was amplified from mEGFP-N1 (a kind gift from Michael Davidson, Addgene plasmid 54767), were genetically fused via P2A translational skipping sequence and were cloned in the Sleeping Beauty transposon plasmid with the human elongation factor 1α promoter.19 (link) This plasmid, pT2-EF-OVA-mEGFP, was electroporated together with the Sleeping Beauty Transposase plasmid, pCMV(CAT)T7-SB100 (a gift from Zsuzsanna Izsvak; Addgene plasmid #34 87920 (link)), into TRAMP-C2 by Nucleofector 4D instrument. The electroporated cells were kept in maintenance medium (DMEM supplemented with 10% FBS, 0.005 mg/mL bovine insulin, 1 nM DHT and cell sorted based on mEGFP expression using FACS Aria I cell sorter. The expression of OVA on sorted cells were confirmed by western blotting using rabbit polyclonal OVA antibody (ab186717) at 1:4000 dilution and flow cytometry using PE anti-mouse H-2Kb bound to SIINFEKL (BioLegend) before incubating with or without MCTP-39 for 48 hours. The expression of OVA was analyzed after 48 hours by flow cytometry using BDLSRIIA cytometer, and data were analyzed by FCS Express V.7 Research Edition.
+ Open protocol
+ Expand
4

OT1 Cell-Mediated Cytotoxicity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Splenocytes were harvested from 6- to 12-week-old naïve OT1 male and female mice and plated at 1 × 106 cells/mL with 1 μg/mL SIINFEKL and 100 U/mL recombinant mouse IL-2 (BioLegend). Culture media was replaced on day 3. On day 5, cells were harvested and incubated with RMS-OVA cells at various effector:target ratios for 4 hours. Target cell viability was assessed by incubation with 50 μg propidium iodide followed by flow cytometry, gating on GFP+ tumor cells.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!